• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Iterum Therapeutics plc

Iterum Therapeutics Reports Employment Inducement Grant
January 11, 2023
From Iterum Therapeutics plc
Via GlobeNewswire
Tickers ITRM
Iterum Therapeutics announces Issuance of Allowance for a U.S. Patent Covering Oral Sulopenem
December 15, 2022
From Iterum Therapeutics plc
Via GlobeNewswire
Tickers ITRM
Iterum Therapeutics Reports Third Quarter 2022 Financial Results
November 10, 2022
From Iterum Therapeutics plc
Via GlobeNewswire
Tickers ITRM
Iterum Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on November 10, 2022
November 03, 2022
From Iterum Therapeutics plc
Via GlobeNewswire
Tickers ITRM
Iterum Announces First Patient Dosed in REASSURE, a Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
October 20, 2022
From Iterum Therapeutics plc
Via GlobeNewswire
Tickers ITRM
Iterum Therapeutics to Present Data at IDWeek 2022
October 17, 2022
From Iterum Therapeutics plc
Via GlobeNewswire
Tickers ITRM
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap